Loading…
Adverse effects of COVID-19 vaccines and measures to prevent them
Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated indi...
Saved in:
Published in: | Virology journal 2022-06, Vol.19 (1), p.100-3, Article 100 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633 |
---|---|
cites | cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633 |
container_end_page | 3 |
container_issue | 1 |
container_start_page | 100 |
container_title | Virology journal |
container_volume | 19 |
creator | Yamamoto, Kenji |
description | Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients. |
doi_str_mv | 10.1186/s12985-022-01831-0 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A706149227</galeid><doaj_id>oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7</doaj_id><sourcerecordid>A706149227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbK3-AS9kwCsvpub740ZYtlYXCgW_8C5kkpPtLDuTNZlZ9N832621A5KLJOe85-Gcw1tVrzE6x1iJ9xkTrXiDCGkQVhQ36El1iiWjDSPk59NH75PqRc4bhCgRUj-vTigXXAslT6vFwu8hZaghBHBjrmOol9c_VhcN1vXeOtcNkGs7-LoHm6dUPmOsdwn2MIz1eAP9y-pZsNsMr-7vs-r75cdvy8_N1fWn1XJx1ThO5NgQ66WUFpD3LThwrVdEstYJJEgg3NPAFUgSPNGcEihCppzgiuk2eCooPatWR66PdmN2qett-mOi7cxdIKa1sWns3BaMdUAobp1FTjPJmLXKc--gjA-Oe1lYH46s3dT2UDLDmOx2Bp1nhu7GrOPeaCzKTnEBvL0HpPhrgjyaTZzSUOY3ZcWKYCY1-qda29JVN4RYYK7vsjMLiQRmmpBDM-f_UZXjoe9cHCB0JT4reDcrKJoRfo9rO-VsVl-_zLXkqHUp5pwgPAyJkTm4yBxdZIqLzJ2LzKHvN4_X81Dy1zb0FvmRwJk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678214790</pqid></control><display><type>article</type><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Yamamoto, Kenji</creator><creatorcontrib>Yamamoto, Kenji</creatorcontrib><description>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</description><identifier>ISSN: 1743-422X</identifier><identifier>EISSN: 1743-422X</identifier><identifier>DOI: 10.1186/s12985-022-01831-0</identifier><identifier>PMID: 35659687</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acetaminophen ; Acquired immune deficiency syndrome ; AIDS ; Antibiotics ; Antibodies ; Body temperature ; Cigarette smoking ; Comment ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Critically ill patients ; Disease prevention ; Drug addiction ; Drug dosages ; Herpes zoster ; Host-virus relationships ; Immune response ; Immunosuppression ; Immunosuppressive agents ; Infections ; Inflammation ; Lipids ; mRNA vaccines ; Nanoparticles ; Nonsteroidal anti-inflammatory drugs ; Observations ; Older people ; Pandemics ; Patients ; Propofol ; Proteins ; Risk factor ; Risk factors ; Severe acute respiratory syndrome coronavirus 2 ; Spike protein ; Surgery ; Thrombocytopenia ; Vaccination ; Vaccine-acquired immunodeficiency syndrome ; Vaccines</subject><ispartof>Virology journal, 2022-06, Vol.19 (1), p.100-3, Article 100</ispartof><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</citedby><cites>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167431/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2678214790?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,38516,43895,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35659687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Kenji</creatorcontrib><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><title>Virology journal</title><addtitle>Virol J</addtitle><description>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</description><subject>Acetaminophen</subject><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antibiotics</subject><subject>Antibodies</subject><subject>Body temperature</subject><subject>Cigarette smoking</subject><subject>Comment</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Critically ill patients</subject><subject>Disease prevention</subject><subject>Drug addiction</subject><subject>Drug dosages</subject><subject>Herpes zoster</subject><subject>Host-virus relationships</subject><subject>Immune response</subject><subject>Immunosuppression</subject><subject>Immunosuppressive agents</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Lipids</subject><subject>mRNA vaccines</subject><subject>Nanoparticles</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Observations</subject><subject>Older people</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Propofol</subject><subject>Proteins</subject><subject>Risk factor</subject><subject>Risk factors</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike protein</subject><subject>Surgery</subject><subject>Thrombocytopenia</subject><subject>Vaccination</subject><subject>Vaccine-acquired immunodeficiency syndrome</subject><subject>Vaccines</subject><issn>1743-422X</issn><issn>1743-422X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhgdRbK3-AS9kwCsvpub740ZYtlYXCgW_8C5kkpPtLDuTNZlZ9N832621A5KLJOe85-Gcw1tVrzE6x1iJ9xkTrXiDCGkQVhQ36El1iiWjDSPk59NH75PqRc4bhCgRUj-vTigXXAslT6vFwu8hZaghBHBjrmOol9c_VhcN1vXeOtcNkGs7-LoHm6dUPmOsdwn2MIz1eAP9y-pZsNsMr-7vs-r75cdvy8_N1fWn1XJx1ThO5NgQ66WUFpD3LThwrVdEstYJJEgg3NPAFUgSPNGcEihCppzgiuk2eCooPatWR66PdmN2qett-mOi7cxdIKa1sWns3BaMdUAobp1FTjPJmLXKc--gjA-Oe1lYH46s3dT2UDLDmOx2Bp1nhu7GrOPeaCzKTnEBvL0HpPhrgjyaTZzSUOY3ZcWKYCY1-qda29JVN4RYYK7vsjMLiQRmmpBDM-f_UZXjoe9cHCB0JT4reDcrKJoRfo9rO-VsVl-_zLXkqHUp5pwgPAyJkTm4yBxdZIqLzJ2LzKHvN4_X81Dy1zb0FvmRwJk</recordid><startdate>20220605</startdate><enddate>20220605</enddate><creator>Yamamoto, Kenji</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220605</creationdate><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><author>Yamamoto, Kenji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acetaminophen</topic><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antibiotics</topic><topic>Antibodies</topic><topic>Body temperature</topic><topic>Cigarette smoking</topic><topic>Comment</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Critically ill patients</topic><topic>Disease prevention</topic><topic>Drug addiction</topic><topic>Drug dosages</topic><topic>Herpes zoster</topic><topic>Host-virus relationships</topic><topic>Immune response</topic><topic>Immunosuppression</topic><topic>Immunosuppressive agents</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Lipids</topic><topic>mRNA vaccines</topic><topic>Nanoparticles</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Observations</topic><topic>Older people</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Propofol</topic><topic>Proteins</topic><topic>Risk factor</topic><topic>Risk factors</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike protein</topic><topic>Surgery</topic><topic>Thrombocytopenia</topic><topic>Vaccination</topic><topic>Vaccine-acquired immunodeficiency syndrome</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Kenji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Virology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Kenji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse effects of COVID-19 vaccines and measures to prevent them</atitle><jtitle>Virology journal</jtitle><addtitle>Virol J</addtitle><date>2022-06-05</date><risdate>2022</risdate><volume>19</volume><issue>1</issue><spage>100</spage><epage>3</epage><pages>100-3</pages><artnum>100</artnum><issn>1743-422X</issn><eissn>1743-422X</eissn><abstract>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>35659687</pmid><doi>10.1186/s12985-022-01831-0</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1743-422X |
ispartof | Virology journal, 2022-06, Vol.19 (1), p.100-3, Article 100 |
issn | 1743-422X 1743-422X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7 |
source | Publicly Available Content Database; PubMed Central; Coronavirus Research Database |
subjects | Acetaminophen Acquired immune deficiency syndrome AIDS Antibiotics Antibodies Body temperature Cigarette smoking Comment Coronaviruses COVID-19 COVID-19 vaccines Critically ill patients Disease prevention Drug addiction Drug dosages Herpes zoster Host-virus relationships Immune response Immunosuppression Immunosuppressive agents Infections Inflammation Lipids mRNA vaccines Nanoparticles Nonsteroidal anti-inflammatory drugs Observations Older people Pandemics Patients Propofol Proteins Risk factor Risk factors Severe acute respiratory syndrome coronavirus 2 Spike protein Surgery Thrombocytopenia Vaccination Vaccine-acquired immunodeficiency syndrome Vaccines |
title | Adverse effects of COVID-19 vaccines and measures to prevent them |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20effects%20of%20COVID-19%20vaccines%20and%20measures%20to%20prevent%20them&rft.jtitle=Virology%20journal&rft.au=Yamamoto,%20Kenji&rft.date=2022-06-05&rft.volume=19&rft.issue=1&rft.spage=100&rft.epage=3&rft.pages=100-3&rft.artnum=100&rft.issn=1743-422X&rft.eissn=1743-422X&rft_id=info:doi/10.1186/s12985-022-01831-0&rft_dat=%3Cgale_doaj_%3EA706149227%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2678214790&rft_id=info:pmid/35659687&rft_galeid=A706149227&rfr_iscdi=true |